Literature DB >> 26676700

Pathophysiology of Overactive Bladder.

En Meng1, Wei-Yu Lin1, Wei-Chia Lee1, Yao-Chi Chuang1.   

Abstract

Overactive bladder syndrome (OAB), characterized by urinary frequency, nocturia and urgency with or without incontinence, is a widespread medical condition with significant impact on quality of life. Three main factors have been proposed regarding the cause of OAB: myogenic, neurogenic and urotheliogenic. Disturbance of any of the three factors or a combination of these factors can attribute to OAB. Metabolic derangement, bladder outlet obstruction and inflammation can increase the excitability of nerve, detrusor muscle and alter the sensory and barrier functions of the urothelium. The detection of proteins in the urine such as NGF, PGE2, and proinflammatory chemokines may advance our understanding of the pathophysiology of OAB and offer novel diagnostic biomarkers of OAB.
© 2012 Blackwell Publishing Asia Pty Ltd.

Entities:  

Keywords:  inflammation; metabolic syndrome; overactive bladder; pathophysiology; urothelium

Year:  2012        PMID: 26676700     DOI: 10.1111/j.1757-5672.2011.00122.x

Source DB:  PubMed          Journal:  Low Urin Tract Symptoms        ISSN: 1757-5664            Impact factor:   1.592


  16 in total

Review 1.  The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.

Authors:  Karl-Erik Andersson; Donna B Boedtkjer; Axel Forman
Journal:  Ther Adv Urol       Date:  2016-11-04

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 3.  Clinical epidemiological insights into urinary incontinence.

Authors:  Vatché A Minassian; Tony Bazi; Walter F Stewart
Journal:  Int Urogynecol J       Date:  2017-03-20       Impact factor: 2.894

4.  Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A.

Authors:  Qinggang Liu; Limin Liao
Journal:  Int Neurourol J       Date:  2022-06-30       Impact factor: 3.038

Review 5.  Understanding clinic options for overactive bladder.

Authors:  Jamie M Bartley; Emily S Blum; Larry T Sirls; Kenneth M Peters
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 6.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 7.  Pharmacological treatment of chronic pelvic ischemia.

Authors:  Karl-Erik Andersson; Masanori Nomiya; Norifumi Sawada; Osamu Yamaguchi
Journal:  Ther Adv Urol       Date:  2014-06

Review 8.  Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review.

Authors:  Zara Khizer; Amina Sadia; Raman Sharma; Samia Farhaj; Jorabar Singh Nirwan; Pratibha G Kakadia; Talib Hussain; Abid Mehmood Yousaf; Yasser Shahzad; Barbara R Conway; Muhammad Usman Ghori
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-26

9.  Maternal Fructose Exposure Programs Metabolic Syndrome-Associated Bladder Overactivity in Young Adult Offspring.

Authors:  Wei-Chia Lee; You-Lin Tain; Kay L H Wu; Steve Leu; Julie Y H Chan
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

10.  Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?

Authors:  Yuh-Chen Kuo; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2016-03-16       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.